#USA #Veeva Systems #Pleasanton #Vault CRM #Bristol Myers

Bristol Myers Squibb Adopts Veeva Vault CRM

In a significant move to enhance customer relations and streamline its operational processes, Bristol Myers Squibb (BMS) has officially committed to using Veeva Vault CRM. This decision was announced by Veeva Systems, a leading provider of cloud-based services for the life sciences industry, during a press conference held on September 22, 2025.

Transforming Customer Engagement

According to Greg Meyers, the executive vice president and chief digital and technology officer at BMS, technology is reshaping how healthcare companies interact with medical professionals and their patients. The implementation of Veeva Vault CRM represents a strategic advancement in their relationship with Veeva. Meyers commented, "We are excited to take the next step in our long-standing relationship with Veeva by using Vault CRM. This will help transform how healthcare practitioners make informed decisions regarding the increasingly complex array of innovative medicines available today."

The integration of Veeva’s CRM system aims to revolutionize every aspect of the customer interaction process, from delivering essential information about BMS's extensive medicine portfolio to facilitating deeper engagement with their field representatives. The adoption of advanced technologies, particularly artificial intelligence, is positioned to allow BMS to provide a more personalized and efficient experience for healthcare practitioners.

AI at the Core of Innovation

The forthcoming Veeva AI agents play a crucial role in this initiative, designed to enrich the customer journey across various touchpoints. Anticipated to be launched in December 2025, the AI agents include Pre-call Agent, Content Agent, Free Text Agent, and Voice Agent. These innovations are expected to give healthcare professionals quicker access to vital treatment information, enhancing decision-making processes effectively.

Meyers added, "By embedding AI into every step of the customer journey, from how practitioners receive valuable information about our offerings to how they coordinate with our field force, Veeva is ideally positioned to support us in our mission to deliver life-changing medicines to patients globally."

Peter Gassner, CEO of Veeva, expressed gratitude for BMS's trust in their partnership, stating, "We appreciate the trust and partnership and are committed to supporting Bristol Myers Squibb in their mission to provide medicines that transform the lives of patients with serious diseases." He emphasized that the introduction of Vault CRM represents not just an upgrade, but the next generation of customer relationship management enhanced by AI agents.

About Veeva Systems

Veeva Systems has established itself as a leader in providing industry-specific cloud solutions tailored for life sciences businesses. Their commitment spans software, data, and business consulting, dedicated to innovation and product excellence. Serving over 1,500 customers, including large biopharmaceutical companies and emerging biotech firms, Veeva holds the distinction of being a Public Benefit Corporation, striving to balance the interests of all stakeholders involved.

For more details about Veeva and its initiatives, visit veeva.com.

Conclusion

The strategic alliance between Bristol Myers Squibb and Veeva Systems through the adoption of the Vault CRM illustrates a vital step towards integrating technology into healthcare. This initiative not only aims to improve practitioner engagement but fundamentally shifts how patients receive effective treatment pathways, leveraging innovative and time-efficient solutions in a complex healthcare landscape.